Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 1/2013

01-01-2013 | Letter to the Editor

A case of Langerhans cell histiocytosis following acute basophilic leukemia

Authors: Tae-Dong Jeong, Seongsoo Jang, Chan-Jeoung Park, Hyun-Sook Chi, Je-Hwan Lee

Published in: Annals of Hematology | Issue 1/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG (1994) Langerhans'-cell histiocytosis (histiocytosis X)—a clonal proliferative disease. N Engl J Med 331(3):154–160PubMedCrossRef
2.
Egeler RM, Neglia JP, Arico M, Favara BE, Heitger A, Nesbit ME (1994) Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol 23(2):81–85PubMedCrossRef
3.
Egeler RM, Neglia JP, Arico M, Favara BE, Heitger A, Nesbit ME, Nicholson HS (1998) The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am 12(2):369–378PubMedCrossRef
4.
Egeler RM, Neglia JP, Puccetti DM, Brennan CA, Nesbit ME (1993) Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 71(3):865–873PubMedCrossRef
5.
Billings SD, Hans CP, Schapiro BL, Martin RW 3rd, Fivenson D, Fruland JE, Moores WB, Cotton J (2006) Langerhans cell histiocytosis associated with myelodysplastic syndrome in adults. J Cutan Pathol 33(2):171–174PubMedCrossRef
6.
Ghosn MG, Haddad AC, Nassar MN, Abadjian GA, El Karak FR, Aftimos PG (2010) Acute myeloid leukemia and Langerhans' cell histiocytosis: multiple theories for an unusual presentation. Leuk Res 34(3):406–408PubMedCrossRef
Metadata
Title
A case of Langerhans cell histiocytosis following acute basophilic leukemia
Authors
Tae-Dong Jeong
Seongsoo Jang
Chan-Jeoung Park
Hyun-Sook Chi
Je-Hwan Lee
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 1/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-012-1542-y

Other articles of this Issue 1/2013

Annals of Hematology 1/2013 Go to the issue

Original Article

Interrelationship and expression profiling of cyclooxygenase and angiogenic factors in Indian patients with multiple myeloma

Original Article

Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China

Original Article

Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin

Original Article

Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS)

Letter to the Editor

Transient lupus anticoagulant with a prolonged activated partial thromboplastin time secondary to cytomegalovirus-related infectious mononucleosis

Original Article

Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits